A Quick Look at Today's Ratings for OptimizeRx(OPRX.US), With a Forecast Between $12.5 to $22
OptimizeRx Price Target Raised to $12.50/Share From $8.00 by Stifel
OptimizeRx Is Maintained at Buy by Stifel
JMP Securities Maintains Market Outperform on OptimizeRx, Raises Price Target to $14
OptimizeRx Analyst Ratings
B. Riley Adjusts Price Target on OptimizeRx to $18 From $13, Maintains Buy Rating
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
William Blair Maintains OptimizeRx(OPRX.US) With Buy Rating
Roth MKM Maintains OptimizeRx(OPRX.US) With Buy Rating, Raises Target Price to $22
OptimizeRx (OPRX) Gets a Buy From Roth MKM
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
OptimizeRx (OPRX) Gets a Buy From Lake Street
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
A Quick Look at Today's Ratings for OptimizeRx(OPRX.US), With a Forecast Between $8 to $16
OptimizeRx's Strong Q4 2024 Performance and Positive Outlook Justify Buy Rating
Lake Street Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $11
Lake Street Reaffirms Their Buy Rating on OptimizeRx (OPRX)